Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 12/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 11/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TYR | P14679 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | AR | P10275 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.65 |
| ▸ | HTR6 | P50406 | 1/20 | 0.65 |
| ▸ | ESRRG | P62508 | 1/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | SHBG | P04278 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10781469 | 0.92 | ESR1 (0.56) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL19792143 | 0.92 | ESR1 (0.80) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL196799 | 0.87 | MEN1 (0.48) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL20673138 | 0.82 | ESR1 (0.65) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL6036607 | 0.82 | ESR1 (0.65) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL13917765 | 0.82 | ESR1 (0.65) | ESR1ESR2CYP3A4LMNATYR | |
| Phenol SCHEMBL10440204 | 0.81 | ESR2 (0.60) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL18802754 | 0.79 | KIF11 (0.44) | ESR1ESR2CYP3A4LMNATYR | |
| Bisphenol A SCHEMBL15062 | 0.79 | ESR1 (1.00) | ESR1ESR2CYP3A4LMNATYR | |
| Bisphenol A SCHEMBL9774987 | 0.79 | ESR1 (1.00) | ESR1ESR2CYP3A4LMNATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114381484-B | Application of UGT85A1 or RrUGT3 in catalyzing various substrates to generate glycoside compounds | 山东大学 | 2024-04-19 | — | — | CN | claimed |
| CN-114381484-A | Application of UGT85A1 or RrUGT3 in catalyzing various substrates to generate glycoside compounds | 山东大学 | 2022-04-22 | — | — | CN | claimed |
| EP-1109770-A1 | A METHOD FOR PREPARING BISPHENOL A | GENERAL ELECTRIC COMPANY (US) | 2001-06-27 | — | — | EP | claimed |
| US-6197916-B1 | Method for preparing bisphenol A | GENERAL ELECTRIC COMPANY | 2001-03-06 | — | — | US | claimed |
| WO-2000012455-A1 | A METHOD FOR PREPARING BISPHENOL A | GENERAL ELECTRIC COMPANY (US) | 2000-03-09 | — | — | WO | claimed |
| US-5990362-A | Method for preparing bisphenol A | GENERAL ELECTRIC COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| CN-121571169-A | Catalyst based on cobalt-molybdenum bimetallic sulfide heterostructure and preparation method and application thereof | 齐鲁工业大学(山东省科学院) | 2026-02-27 | — | — | CN | disclosed |
| US-12421193-B2 | GPR52 modulators and methods of use | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| CN-119859118-A | Synthesis method of 4- (2-hydroxy-2-propyl) cumene hydroperoxide | 中国石油化工股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| US-20250122188-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2025-04-17 | — | — | US | disclosed |
| US-20240166652-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ABBVIE INC. | 2024-05-23 | — | — | US | disclosed |
| EP-4356971-A2 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Calico Life Sciences LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| US-4307223-A | CONTAINING PHENOLIC CONSTITUENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4258219-A | Process for producing hydroquinone | MITSUI TOATSU CHEMICALS, INC. (JP) | 1981-03-24 | — | — | US | disclosed |
| EP-0021848-A1 | Process and apparatus for the preparation of phenols | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-01-07 | — | — | EP | disclosed |
| US-4237035-A | FOR COATINGS, ADHESIVES, MOLDING MATERIALS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-12-02 | — | — | US | disclosed |
| US-4230890-A | PRECIPITATION BY TREATING AN ORGANIC SOLUTION OF HYDROCARBON OXIDATES WITH AN ALKALI METAL HYDROXIDE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-4207264-A | DISCOLORATION INHIBITION | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-06-10 | — | — | US | disclosed |
| US-4045499-A | ACID CATALYSTS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122188-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | ESR1 1100/4885ESR2 482/4885CYP3A4 3526/4885 |
| US-20240166652-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | ESR1 1100/4885ESR2 482/4885CYP3A4 3526/4885 |
| US-12421193-B2 | GPR52 modulators and methods of use | GPR52, GPR68, GPR35 | ESR1 644/4885ESR2 219/4885CYP3A4 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.